Alcedis

Alcedis specializes in digitalizing and managing clinical research with over three decades of experience. It pioneered Germany’s first web-based electronic case report form (eCRF) system and has managed nearly one thousand studies globally across diverse therapeutic areas. In January 2023, it was acquired by Huma Therapeutics to form an advanced digital clinical trials division offering solutions from early-stage through Phase IV hybrid/decentralized trials. The company’s expertise includes patient recruitment services, data management, medical imaging integration, real-world evidence generation, and the deployment of mobile/digital tools to enhance trial efficiency.